AI-Powered Medical Devices

Elekta Debuts Its Linear Accelerator Technology, Named Evo

Elekta, a provider of radiation therapy systems, has formally launched a new model of its linear accelerator technology — dubbed Evo — within the Indian healthcare market. This follows the innovation's prior introductions in Europe and other global regions.

Evo integrates diagnostic-quality computed tomography (CT) scanning directly with the radiation delivery mechanism. This configuration is designed to facilitate a treatment methodology known as online adaptive radiotherapy, wherein treatment plans can be modified immediately prior to a session based on the patient's anatomy captured that day.

Elekta emphasizes that this technological combination, which is supported by artificial intelligence for image enhancement and contouring processes, is intended to address clinical challenges associated with treating complex and advanced-stage cancers.

Image Credit: Elekta

AI-enhanced Imaging
Integrating AI into medical imaging allows for dynamic, real-time enhancements, providing clearer insights during complex cancer treatments.
Adaptive Radiotherapy Solutions
Real-time adaptation of treatment plans based on updated patient anatomy enables personalized and precise radiation therapy sessions.
Integrated Treatment Platforms
Combining diagnostic and treatment technologies in one platform enhances efficiency and patient outcomes in oncology care.

Who This Affects Most

Healthcare Technology
Innovations in technology are transforming the delivery of medical care, particularly in the realm of cancer treatment.
Artificial Intelligence
AI's role in healthcare is expanding, with applications ranging from image processing to treatment personalization.
Medical Devices
Development of advanced equipment integrating multiple functions is reshaping the landscape for medical device manufacturers.
SCORE
6.7 out of 10
GENDER
50% Men50% Women
MARKETTop markets: Asia
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial
  • Gen X (primary audience)
POPULARITY
Popularity 64%
Activity 70%
Freshness 66%